TOSOH Aktie

>TOSOH Aktienkurs

12.85 EUR (TradegateBSX)

Ask: 13 EUR / 385 Stück

Bid: 12.7 EUR / 396 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

TOSOH Aktie über LYNX handeln

Intraday

1 Jahr

>TOSOH Performance

1 Woche: +3,2%

1 Monat: -4,8%

3 Monate: -0,4%

6 Monate: +1,6%

1 Jahr: +7,1%

laufendes Jahr: 0%

>TOSOH Aktie

Name:

TOSOH CORP.

Land:

Japan

Sektor:

Chemie

ISIN/ Wkn:

JP3595200001 / 859557

Symbol/ Ticker:

TOS (Frankfurt)

Kürzel:

FRA:TOS, ETR:TOS, TOS:GR

Index:

Nikkei225

Webseite:

http://www.tosoh.com/

Profil:

Tosoh Corporation is a diversified chemical manufacturing company that plays a pivotal role in supplying a wide array of products to various industries globally. Founded in 1935 and headquartered in Tokyo, Japan, Tosoh's primary function is to produc..
>Volltext..

Marktkapitalisierung:

4130.08 Mio. EUR

Unternehmenswert:

4956.37 Mio. EUR

Umsatz:

5659.32 Mio. EUR

EBITDA:

791.46 Mio. EUR

Nettogewinn:

188.54 Mio. EUR

Gewinn je Aktie:

0.6 EUR

Schulden:

1151.66 Mio. EUR

Liquide Mittel:

754.16 Mio. EUR

Operativer Cashflow:

729.51 Mio. EUR

Bargeldquote:

0.4

Umsatzwachstum:

-14.06%

Gewinnwachstum:

-53.23%

Dividende je Aktie:

0.28 EUR

Dividendenrendite:

4.18%

Dividendenschätzung:

4.23%

Div. Historie:

29.09.25 - 0.28488€
28.03.25 - 0.28488€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

TOSOH

Letzte Datenerhebung:

05.04.26

>TOSOH Kennzahlen

Aktien/ Unternehmen:

Aktien: 310.36 Mio. St.

Frei handelbar: 76.67%

Leerverk. Aktien: -

Rückkaufquote: 2.51%

Mitarbeiter: 14813

Umsatz/Mitarb.: 0.41 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 8.85%

Bewertung:

KGV: 21.37

KGV lG: 19.41

KUV: 0.71

KBV: 0.89

PEG-Ratio: -

EV/EBITDA: 6.26

Rentabilität:

Bruttomarge: 25.11%

Gewinnmarge: 3.33%

Operative Marge: 9.2%

Managementeffizenz:

Gesamtkaprendite: 2.55%

Eigenkaprendite: 4.22%

>TOSOH Peer Group

Chemie, Spezialchemie

>TOSOH Chart & Kurs - Tradegate

>TOSOH News

05.02.26 - 06:30	Tosoh Corporation Profit Drops In Nine Months (AFX)
	TOKYO (dpa-AFX) - Tosoh Corporation (TOS.F) announced earnings for nine months that Dropped, from the same period last yearThe company's bottom line came in at JPY24.629 billion, or JPY77.93 per s......

01.12.25 - 15:06

Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO (Business Wire)

Industry veteran brings two decades of platform commercialization experience in cell therapy, bioprocessing, and bioanalytics as Cellares prepares to support multiple clinical trials in 2026 Appointment follows five global manufacturing agreements with partners, including Bristol Myers Squibb, Kite, and leading academic institutions, as well as the FDA's first Advanced Manufacturing Technology designation for a cell therapy manufacturing platform. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced the appointment of Ali Soleymannezhad as Chief Commercial Officer. Soleymannezhad, formerly Chief Commercial Officer at MaxCyte (NASDAQ: MXCT) and Executive Vice President at Tosoh Bioscience, will lead global commercial strategy as the company deploys its network of IDMO Smart Factories across the United States, Europe, and Japan. Soleymannezhad's appointment is key to driving the commercial expansion and pipeline gro...

04.11.25 - 07:18	Tosoh H1 Earnings Fall (AFX)
	TOKYO (dpa-AFX) - Tosoh Corp. (4042.T, TOSCF), a Japanese chemical and specialty materials company, on Tuesday announced that net income decreased in the first half compared with the previous year......

30.10.25 - 21:09	Tosoh Bioscience Receives FDA 510(k) Clearance for Fast, Accurate GR01 HbA1c Testing Analyzer (PR Newswire)
	GROVE CITY, Ohio, Oct. 30, 2025 /PRNewswire/ -- Tosoh Bioscience, Inc., a market leader in clinical diagnostics has received U.S. FDA 510(k) clearance for its next-generation Tosoh Automated Glycohemoglobin Analyzer HLC®-723 GR01 (GR01) for HbA1c testing. The GR01 Analyzer is designed for......

06.10.25 - 20:03	Tosoh Announces 510k Clearance for Highly Anticipated Next-Generation GR01 HbA1c Analyzer: A Fast, Accurate and Efficient Solution for A1c Testing (PR Newswire)
	GROVE CITY, Ohio, Oct. 6, 2025 /PRNewswire/ -- Tosoh Bioscience, Inc., a market leader in clinical diagnostics is proud to announce that it has received US FDA 510(k) clearance for its next-generation system for HbA1c testing - the Tosoh Automated Glycohemoglobin Analyzer HLC®723-GR01......

05.08.25 - 07:48	Tosoh Corporation Bottom Line Falls In Q1 (AFX)
	TOKYO (dpa-AFX) - Tosoh Corporation (TOS.F) revealed a profit for first quarter that Drops, from last yearThe company's earnings came in at JPY6.53 billion, or JPY20.50 per share. This compares wi......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram